Two Chinese alliances for Amerigen as it pursues branded generics opportunities
This article was originally published in Scrip
Executive Summary
The privately held US/Chinese firm Amerigen Pharmaceuticals has joined the ranks of companies building up their branded generics businesses in China through two alliances it hopes will extend its reach in this growing sector.